<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Patients with <z:hpo ids='HP_0001300'>parkinsonism</z:hpo> pose a diagnostic challenge </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="C0030567" disease_type="Disease or Syndrome" abbrv="PD">Parkinson's disease</z:e> may be difficult to distinguish from multiple system <z:mpath ids='MPATH_127'>atrophy</z:mpath> and <z:e sem="disease" ids="C0038868" disease_type="Disease or Syndrome" abbrv="PSNP1">progressive supranuclear palsy</z:e>, whereas <z:e sem="disease" ids="C0030567" disease_type="Disease or Syndrome" abbrv="PD">Parkinson's disease</z:e> and <z:hpo ids='HP_0000726'>dementia</z:hpo> with <z:hpo ids='HP_0100315'>Lewy bodies</z:hpo> can be difficult to distinguish from <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> and other <z:hpo ids='HP_0000726'>dementias</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>A number of studies have found diminished cardiac (123) I-metaiodobenzylguanidine uptake in Lewy body-related conditions (<z:e sem="disease" ids="C0030567" disease_type="Disease or Syndrome" abbrv="PD">Parkinson's disease</z:e> and Lewy body <z:hpo ids='HP_0000726'>dementia</z:hpo>) </plain></SENT>
<SENT sid="3" pm="."><plain>In 2005, the <z:hpo ids='HP_0000726'>Dementia</z:hpo> With <z:hpo ids='HP_0100315'>Lewy Bodies</z:hpo> Consortium considered (123) I-metaiodobenzylguanidine cardiac scintigraphy a "supportive" diagnostic feature, based on limited evidence </plain></SENT>
<SENT sid="4" pm="."><plain>We report a meta-analysis of the literature and an assessment of the utility of (123) I-metaiodobenzylguanidine for the diagnosis of <z:hpo ids='HP_0000726'>dementia</z:hpo> with <z:hpo ids='HP_0100315'>Lewy bodies</z:hpo> and <z:e sem="disease" ids="C0030567" disease_type="Disease or Syndrome" abbrv="PD">Parkinson's disease</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>A search was conducted of articles published between 1950 and June 2010 </plain></SENT>
<SENT sid="6" pm="."><plain>Forty-six studies involving neuropsychiatric and <z:hpo ids='HP_0100022'>movement disorders</z:hpo>, comprising 2680 subjects, were included in the analysis </plain></SENT>
<SENT sid="7" pm="."><plain>A mixed-effects regression model was used to analyze the delayed mean heart-to-mediastinum ratio of (123) I-metaiodobenzylguanidine uptake </plain></SENT>
<SENT sid="8" pm="."><plain>(123) I-metaiodobenzylguanidine cardiac scintigraphy sensitively detected and specifically distinguished 2 diagnostic clusters: (1) <z:e sem="disease" ids="C0030567" disease_type="Disease or Syndrome" abbrv="PD">Parkinson's disease</z:e>, <z:hpo ids='HP_0000726'>dementia</z:hpo> with <z:hpo ids='HP_0100315'>Lewy bodies</z:hpo>, and <z:e sem="disease" ids="C0751772" disease_type="Disease or Syndrome" abbrv="">rapid eye movement sleep behavior disorder</z:e>; and (2) <z:mpath ids='MPATH_458'>normal</z:mpath> controls and patients with <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e>, multiple system <z:mpath ids='MPATH_127'>atrophy</z:mpath>, <z:e sem="disease" ids="C0038868" disease_type="Disease or Syndrome" abbrv="PSNP1">progressive supranuclear palsy</z:e>, vascular <z:hpo ids='HP_0000726'>dementia</z:hpo>, and <z:hpo ids='HP_0002145'>frontotemporal dementia</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>The area under the receiver operating characteristic curve was 0.987 at a cluster discriminatory heart-to-mediastinum ratio threshold of 1.77 </plain></SENT>
<SENT sid="10" pm="."><plain>This threshold yielded 94% sensitivity and 91% specificity for the discrimination of these diagnostic clusters </plain></SENT>
<SENT sid="11" pm="."><plain>(123) I-metaiodobenzylguanidine cardiac scintigraphy can accurately distinguish between 2 <z:hpo ids='HP_0100022'>movement disorders</z:hpo>, <z:e sem="disease" ids="C0030567" disease_type="Disease or Syndrome" abbrv="PD">Parkinson's disease</z:e> and multiple system <z:mpath ids='MPATH_127'>atrophy</z:mpath>, and between 2 common causes of <z:hpo ids='HP_0000726'>dementia</z:hpo>, <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> and <z:hpo ids='HP_0000726'>dementia</z:hpo> with <z:hpo ids='HP_0100315'>Lewy bodies</z:hpo>. Â© 2011 <z:hpo ids='HP_0100022'>Movement Disorder</z:hpo> Society </plain></SENT>
</text></document>